Ausicare India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 23356.30%
- Profit Growth 59.42%
- Ebitda -51.97%
- Net Worth -16.41%
- Total Assets 46.30%
About Ausicare India
Ausicare India Private Limited (AIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 22 March 2021 (Three years and ten months 12 days old ). Its registered office is in Howrah, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Kiran Singh and Sumit Singh serve as directors at the Company.
Company Details
-
Location
Howrah, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85200WB2021FTC244078
-
Company No.
244078
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
22 Mar 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Ausicare India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Singh
|
Director | 20-Nov-2021 | Current |
|
Sumit Singh
|
Director | 27-Sep-2021 | Current |
Financial Performance of Ausicare India.
Ausicare India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23356.3% increase. The company also saw a substantial improvement in profitability, with a 59.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ausicare India?
Unlock access to Ausicare India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Austex Pharmaceutical Private LimitedSumit Singh is a mutual person
-
Ausilabs Private LimitedKiran Singh and Sumit Singh are mutual person
-
Jmt Investment Private Limited
Kiran Singh is a mutual person
-
Austex International School Private Limited
Kiran Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ausicare India?
Ausicare India has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ausicare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ausicare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
